Rocket One (RKTO) Consolidated Net Income (2018 - 2026)
Rocket One's (RKTO) quarterly Consolidated Net Income came in at -$3.8 million in Q2 2026, down 74.34% year-over-year from -$14.9 million in Q2 2025, and down 44.79% quarter-over-quarter from -$2.6 million in Q1 2026.
Analysis
Rocket One (RKTO) Consolidated Net Income (2018 - 2026) Analysis & Trends
Rocket One has disclosed Consolidated Net Income across 9 years of filings, most recently posting -$3.8 million for Q2 2026.
- In Q2 2026, Consolidated Net Income fell 74.34% year-over-year to -$3.8 million; the TTM figure through Jun 2026 stood at -$13.2 million (down 31.59% YoY), while the FY2025 annual figure was -$12.4 million, down 50.46% from the prior year.
- Consolidated Net Income came in at -$3.8 million for Q2 2026 at Rocket One, down from -$2.6 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of -$1.7 million in Q2 2024 to a low of -$4.1 million in Q3 2025.
- Average Consolidated Net Income over 5 years is -$2.6 million, with a median of -$2.3 million recorded in 2022.
- Year-over-year, Consolidated Net Income surged 47.6% in 2023 and slumped 83.05% in 2025.
- Over 5 years, Consolidated Net Income stood at -$3.4 million in 2022, then surged by 47.6% to -$1.8 million in 2023, then dropped by 17.32% to -$2.1 million in 2024, then decreased by 23.88% to -$2.6 million in 2025, then plunged by 47.2% to -$3.8 million in 2026.
- Per Business Quant data, the three most recent Consolidated Net Income figures were -$3.8 million in Q2 2026, -$2.6 million in Q1 2026, and -$2.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.77 Bn | 197.79 Bn | 7.24 Bn | 2.38 Bn |
| 2 | Gilead Sciences | 181.13 Bn | 177.95 Bn | 6.22 Bn | -10.50 Bn |
| 3 | Vertex Pharmaceuticals | 132.24 Bn | 124.39 Bn | 2.84 Bn | 1.10 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.89 Bn | 3.93 Bn | 1.30 Bn |
| 5 | Argenx Se | 61.56 Bn | 56.38 Bn | 1.37 Bn | 601.00 Mn |
| 6 | Moderna | 54.38 Bn | 49.24 Bn | 52.00 Mn | -782.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.44 Bn | 31.13 Bn | 992.69 Mn | 164.49 Mn |
| 8 | Biogen | 31.17 Bn | 29.89 Bn | 1.96 Bn | 97.50 Mn |
| 9 | Roivant Sciences | 30.12 Bn | 30.12 Bn | 1.16 Mn | -290.61 Mn |
| 10 | Rocket One | 13.80 Mn | 5.90 Mn | - | -3.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.83 Mn |
| Mar 31, 2026 | -2.65 Mn |
| Dec 31, 2025 | -2.61 Mn |
| Sep 30, 2025 | -4.08 Mn |
| Jun 30, 2025 | -2.20 Mn |
| Mar 31, 2025 | -3.48 Mn |
| Dec 31, 2024 | -2.10 Mn |
| Sep 30, 2024 | -2.23 Mn |
| Jun 30, 2024 | -1.72 Mn |
| Mar 31, 2024 | -2.16 Mn |
| Dec 31, 2023 | -1.79 Mn |
| Sep 30, 2023 | -2.18 Mn |
| Jun 30, 2023 | -1.73 Mn |
| Mar 31, 2023 | -2.22 Mn |
| Dec 31, 2022 | -3.42 Mn |
| Sep 30, 2022 | -2.68 Mn |
| Jun 30, 2022 | -2.30 Mn |
| Mar 31, 2022 | -2.85 Mn |
| Dec 31, 2021 | -3.56 Mn |
| Sep 30, 2021 | -3.46 Mn |